| 1 |
34458381 | Interaction of SARS-CoV-2 spike protein with angiotensin converting enzyme inhibitors and selected compounds from the chemical entities of biological interest. | 2021 |
2 |
| 2 |
32991443 | Fabry disease with early-onset ventricular dilation: A case report. | 2020 Sep 25 |
1 |
| 3 |
25845252 | Estimation of angiotensin-converting enzyme inhibitors protein binding degree using chromatographic hydrophobicity data. | 2015 Jan-Feb |
1 |
| 4 |
24556825 | A randomized controlled trial of angiotensin-converting enzyme inhibition for skeletal muscle dysfunction in COPD. | 2014 Oct |
1 |
| 5 |
24986000 | [Comparison of American and European (Czech) guidelines for diagnosis and treatment of chronic heart failure]. | 2014 Apr |
1 |
| 6 |
25188759 | Effects of antihypertensive treatment on cardiovascular autonomic control: a prospective study. | 2014 Dec |
1 |
| 7 |
25383221 | Docking studies and biological activity of fosinopril analogs. | 2014 |
3 |
| 8 |
20617288 | Effects of ACE-inhibition on IGF-1 and IGFBP-3 concentrations in older adults with high cardiovascular risk profile. | 2010 Jun |
2 |
| 9 |
19185642 | Angiotensin-converting enzyme inhibition and novel cardiovascular risk biomarkers: results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors (TRAIN) study. | 2009 Feb |
1 |
| 10 |
17337423 | Fosinopril H(2)-receptor antagonists interaction studies by derivative spectroscopy. | 2007 Jan |
3 |
| 11 |
16631159 | Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors. | 2006 May 10 |
1 |
| 12 |
16634995 | The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency. | 2006 May |
1 |
| 13 |
16915750 | [Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients]. | 2006 Mar-Apr |
1 |
| 14 |
15938534 | [Effects of ACE inhibitor fosinopril on a 24-h profile of arterial pressure in hypertensive patients with obesity and hypercholesterolemia]. | 2005 |
1 |
| 15 |
16130750 | Development of liquid chromatographic method for fosinoprilat determination in human plasma using microemulsion as eluent. | 2005 Sep 23 |
3 |
| 16 |
16502517 | [Effect of fosinopril on some parameters of endothelial function in patients with metabolic syndrome]. | 2005 |
1 |
| 17 |
15744357 | Heart failure and first dose hypotension after angiotensin converting enzyme inhibitors. | 2004 Dec |
1 |
| 18 |
12925048 | Comparative metabolic effects of hydrochlorothiazide and indapamide in hypertensive diabetic patients receiving ACE inhibitor therapy. | 2003 Sep |
1 |
| 19 |
12602460 | FOSIDIAL: a randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patients' baseline characteristics. | 2002 Oct |
2 |
| 20 |
11436209 | The effects of ACE inhibitor therapy on left ventricular myocardial mass and diastolic filling in previously untreated hypertensive patients: a cine MRI study. | 2001 Jul |
1 |
| 21 |
11560874 | Mechanism of intestinal absorption and renal reabsorption of an orally active ace inhibitor: uptake and transport of fosinopril in cell cultures. | 2001 Oct |
1 |
| 22 |
11826546 | [Effectiveness and tolerance of fosinopril in the treatment of arterial hypertension of mild and medium severity]. | 2001 Dec |
1 |
| 23 |
10666408 | Angiotensin-converting enzyme inhibitors downregulate tissue factor synthesis in monocytes. | 2000 Feb 4 |
1 |
| 24 |
10856268 | In vitro and in vivo inhibition of the 2 active sites of ACE by omapatrilat, a vasopeptidase inhibitor. | 2000 Jun |
3 |
| 25 |
10999650 | Predicting response to chronic antihypertensive treatment with fosinopril: the role of angiotensin-converting enzyme gene polymorphism. | 2000 Aug |
3 |
| 26 |
11030016 | Overview of the angiotensin-converting-enzyme inhibitors. | 2000 Oct 1 |
1 |
| 27 |
11064182 | Cocaine, HIV, and their cardiovascular effects: is there a role for ACE-inhibitor therapy? | 2000 Dec 22 |
1 |
| 28 |
11105370 | Drug-related pemphigus and angiotensin converting enzyme inhibitors. | 2000 Nov |
1 |
| 29 |
11501170 | Effect of valsartan and fosinopril on catecholamine-induced cardiac hypertrophy. | 2000 Sep |
1 |
| 30 |
10194656 | Reversal of peripheral microvascular dysfunction during long-term treatment with the angiotensin-converting enzyme inhibitor fosinopril in congestive heart failure. | 1999 Mar |
3 |
| 31 |
10412878 | Skeletal muscle angiotensin-converting enzyme and its relationship to blood pressure in primary hypertension and healthy elderly men. | 1999 |
2 |
| 32 |
11329095 | The hemodynamic effects of long-term ACE inhibition with fosinopril in patients with heart failure. Fosinopril Hemodynamics Study Group. | 1999 Jul |
1 |
| 33 |
9736436 | Relationships among diabetes, microalbuminuria, and ACE inhibition. | 1998 |
1 |
| 34 |
9736438 | Evidence-based medicine and ACE inhibition. | 1998 |
1 |
| 35 |
9736439 | Neurohormonal markers of clinical outcome in cardiovascular disease: is endothelin the best one? | 1998 |
1 |
| 36 |
9822138 | Comorbidity of hypertension and diabetes: the fosinopril versus amlodipine cardiovascular events trial (FACET) | 1998 Nov 12 |
2 |
| 37 |
9822144 | Calcium antagonists and the diabetic patient: a response to recent controversies. | 1998 Nov 12 |
2 |
| 38 |
9923037 | [Hypoxic eosinophilic pneumonia in two patients treated with ACE inhibitors]. | 1998 Dec |
2 |
| 39 |
9037321 | The alterations in insulin sensitivity during angiotensin converting enzyme inhibitor treatment are related to changes in the calcium/magnesium balance. | 1997 Feb |
1 |
| 40 |
9105649 | Inhibitor index: a novel method for measuring pharmacological inhibition of angiotensin-converting enzyme. | 1997 Mar |
1 |
| 41 |
9186076 | Racial differences in the renal response to blood pressure lowering during chronic angiotensin-converting enzyme inhibition: a prospective double-blind randomized comparison of fosinopril and lisinopril in older hypertensive patients with chronic renal insufficiency. | 1997 Jun |
1 |
| 42 |
9195116 | Fosinopril. Clinical pharmacokinetics and clinical potential. | 1997 Jun |
2 |
| 43 |
9211084 | Fosinopril. A review of its pharmacology and clinical efficacy in the management of heart failure. | 1997 Jul |
1 |
| 44 |
9284425 | [Angiotensin-converting enzyme inhibitors: recent therapeutic aspect]. | 1997 Aug |
2 |
| 45 |
9366278 | An effective approach for treating elderly patients with isolated systolic hypertension: results of an Italian multicenter study with fosinopril. | 1997 Oct |
3 |
| 46 |
9366279 | Treatment of heart failure with fosinopril: an angiotensin converting enzyme inhibitor with a dual and compensatory route of excretion. | 1997 Oct |
2 |
| 47 |
9366282 | Treatment of senile hypertension: the Fosinopril in Old Patients Study (FOPS). | 1997 Oct |
1 |
| 48 |
9366284 | Pharmacoeconomics of angiotensin converting enzyme inhibitors in heart failure. | 1997 Oct |
1 |
| 49 |
9366286 | Treatment of congestive heart failure: experience with fosinopril. | 1997 Oct |
1 |
| 50 |
9446181 | [Therapy of hypertension in the elderly: Fosinopril in Old Patients Study (FOPS)]. | 1997 Nov 5 |
1 |